Nitrite increases glucose-stimulated insulin secretion and islet insulin content in obese type 2 diabetic male rats

Nitric Oxide - Biology and Chemistry

Volumn 64, Issue , 2017, Pages 39-51

  Gheibi, Sevda ^a,b   Bakhtiarzadeh, Fatemeh ^b   Jeddi, Sajad ^b   Farrokhfall, Khadijeh ^c   Zardooz, Homeira ^a   Ghasemi, Asghar ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glucose tolerance; Inflammation; Insulin resistance; Insulin secretion; Nitrite; Type 2 diabetes

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; SODIUM NITRITE; STREPTOZOCIN; TRIACYLGLYCEROL; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CELL ISOLATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EPIDIDYMIS FAT; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID COMPOSITION; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RAT; SOLEUS MUSCLE; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; EATING; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; SECRETION (PROCESS); WISTAR RAT;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; EATING; GLUCOSE; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; NITRIC OXIDE; NITRITES; RATS; RATS, WISTAR;

EID: 85010008102     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2017.01.003     Document Type: Article

References (72)

1. [1] Guariguata, L., Whiting, D., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J., Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 103 (2014), 137–149, 10.1016/j.diabres.2013.11.002.
2. [2] Kasuga, M., Insulin resistance and pancreatic β cell failure. J. Clin. Investigation, 116, 2006, 1756, 10.1172/JCI29189.
3. [3] Carlström, M., Larsen, F.J., Nyström, T., Hezel, M., Borniquel, S., Weitzberg, E., Lundberg, J.O., Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc. Natl. Acad. Sci. 107 (2010), 17716–17720, 10.1073/pnas.1008872107.
4. [4] Bender, S.B., Herrick, E.K., Lott, N.D., Klabunde, R.E., Diet-induced obesity and diabetes reduce coronary responses to nitric oxide due to reduced bioavailability in isolated mouse hearts. Diabetes Obes. Metab. 9 (2007), 688–696, 10.1111/j.1463-1326.2006.00650.x.
5. [5] Gilchrist, M., Winyard, P.G., Aizawa, K., Anning, C., Shore, A., Benjamin, N., Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic. Biol. Med. 60 (2013), 89–97, 10.1016/j.freeradbiomed.2013.01.024.
6. [6] Gruber, H.J., Mayer, C., Mangge, H., Fauler, G., Grandits, N., Wilders-Truschnig, M., Obesity reduces the bioavailability of nitric oxide in juveniles. Int. J. Obes. (Lond) 32 (2008), 826–831, 10.1038/sj.ijo.0803795.
7. [7] Eltahir, E.M., ElGhazali, G., A-Elgadir, T.M.E., A-Elbasit, I.E., Elbashir, M.I., Giha, H.A., Raised plasma insulin level and Homeostasis Model Assessment (HOMA) score in cerebral malaria: evidence for insulin resistance and marker of virulence. Acta Biochim. Pol. 57 (2010), 513–520.
8. [8] Ghasemi, A., Zahediasl, S., Azizi, F., Nitric oxide and clustering of metabolic syndrome components in pediatrics. Eur. J. Epidemiol. 25 (2010), 45–53, 10.1007/s10654-009-9382-3.
9. [9] Hezel, M., Peleli, M., Liu, M., Zollbrecht, C., Jensen, B.L., Checa, A., Giulietti, A., Wheelock, C.E., Lundberg, J.O., Weitzberg, E., Carlstrom, M., Dietary nitrate improves age-related hypertension and metabolic abnormalities in rats via modulation of angiotensin II receptor signaling and inhibition of superoxide generation. Free Radic. Biol. Med. 99 (2016), 87–99, 10.1016/j.freeradbiomed.2016.07.025.
10. [10] Ghasemi, A., Zahediasl, S., Potential therapeutic effects of nitrate/nitrite and type 2 diabetes mellitus. Int. J. Endocrinol. Metabolism 11 (2013), 63–64, 10.5812/ijem.9103.
11. [11] Ohtake, K., Nakano, G., Ehara, N., Sonoda, K., Ito, J., Uchida, H., Kobayashi, J., Dietary nitrite supplementation improves insulin resistance in type 2 diabetic KKA y mice. Nitric Oxide 44 (2015), 31–38, 10.1016/j.niox.2014.11.009.
12. [12] Bahadoran, Z., Ghasemi, A., Mirmiran, P., Azizi, F., Hadaegh, F., Beneficial effects of inorganic nitrate/nitrite in type 2 diabetes and its complications. Nutr. metabolism 12 (2015), 12–16, 10.1186/s12986-015-0013-6.
13. [13] Khalifi, S., Rahimipour, A., Jeddi, S., Ghanbari, M., Kazerouni, F., Ghasemi, A., Dietary nitrate improves glucose tolerance and lipid profile in an animal model of hyperglycemia. Nitric Oxide 44 (2015), 24–30, 10.1016/j.niox.2014.11.011.
14. [14] Peleli, M., Hezel, M., Zollbrecht, C., Persson, A.E.G., Lundberg, J.O., Weitzberg, E., Fredholm, B.B., Carlström, M., In adenosine A2b knockouts acute treatment with inorganic nitrate improves glucose disposal, oxidative stress, and AMPK signaling in the liver. Front. Physiol., 6, 2015, 222, 10.3389/fphys.2015.00222.
15. [15] Jiang, H., Torregrossa, A.C., Potts, A., Pierini, D., Aranke, M., Garg, H.K., Bryan, N.S., Dietary nitrite improves insulin signaling through GLUT4 translocation. Free Radic. Biol. Med. 67 (2014), 51–57, 10.1016/j.freeradbiomed.2013.10.809.
16. [16] Stokes, K.Y., Dugas, T.R., Tang, Y., Garg, H., Guidry, E., Bryan, N.S., Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 296 (2009), H1281–H1288, 10.1152/ajpheart.01291.2008.
17. [17] Natali, A., Ribeiro, R., Baldi, S., Tulipani, A., Rossi, M., Venturi, E., Mari, A., Macedo, M.P., Ferrannini, E., Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion. Diabetologia 56 (2013), 1183–1191, 10.1007/s00125-013-2836-x.
18. [18] Shimabukuro, M., Ohneda, M., Lee, Y., Unger, R.H., Role of nitric oxide in obesity-induced beta cell disease. J. Clin. Investigation, 100, 1997, 290, 10.1172/JCI119534.
19. [19] Sansbury, B.E., Hill, B.G., Regulation of obesity and insulin resistance by nitric oxide. Free Radic. Biol. Med. 73 (2014), 383–399, 10.1016/j.freeradbiomed.2014.05.016.
20. [20] Nystrom, T., Ortsater, H., Huang, Z., Zhang, F., Larsen, F.J., Weitzberg, E., Lundberg, J.O., Sjoholm, A., Inorganic nitrite stimulates pancreatic islet blood flow and insulin secretion. Free Radic. Biol. Med. 53 (2012), 1017–1023, 10.1016/j.freeradbiomed.2012.06.031.
21. [21] Reeves, P.G., Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 127 (1997), 838–841.
22. [22] Ghasemi, A., Zahediasl, S., Preanalytical and analytical considerations for measuring nitric oxide metabolites in serum or plasma using the Griess method. Clin. Lab. 58 (2011), 615–624, 10.7754/Clin.Lab.2011.110908.
23. [23] Ghasemi, A., Tohidi, M., Derakhshan, A., Hasheminia, M., Azizi, F., Hadaegh, F., Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study. Acta diabetol. 52 (2015), 905–915, 10.1007/s00592-015-0730-3.
24. [24] Tohidi, M., Ghasemi, A., Hadaegh, F., Derakhshan, A., Chary, A., Azizi, F., Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin. Biochem. 47 (2014), 432–438, 10.1016/j.clinbiochem.2014.02.007.
25. [25] Lacy, P.E., Kostianovsky, M., Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16 (1967), 35–39, 10.2337/diab.16.1.35.
26. [26] Karbalaei, N., Ghasemi, A., Hedayati, M., Godini, A., Zahediasl, S., The possible mechanisms by which maternal hypothyroidism impairs insulin secretion in adult male offspring in rats. Exp. Physiol. 99 (2014), 701–714, 10.1113/expphysiol.2013.073825.
27. [27] akasha, M., Kerban, A.A., Abobaker, S.a., Effect of nitrate on the body weight, food and water consumption and thyroid hormone in hybrid female rabbits. J. Veterinary Adv. 5 (2015), 912–918, 10.5455/jva.20150517030744.
28. [28] Lai YC, T.D., Dube, J.J., Hughan, K.S., Vanderpool, R.R., Goncharov, D.A., St Croix, C.M., Garcia-Ocaña, A., Goncharova, E.A., Tofovic, S.P., Mora, A.L., Gladwin, M.T., SIRT3-AMPK activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). Circulation 133 (2016), 717–731, 10.1161/CIRCULATIONAHA.115.018935.
29. [29] Roberts, L.D., Ashmore, T., Kotwica, A.O., Murfitt, S.A., Fernandez, B.O., Feelisch, M., Murray, A.J., Griffin, J.L., Inorganic nitrate promotes the browning of white adipose tissue through the nitrate-nitrite-nitric oxide pathway. Diabetes 64 (2015), 471–484, 10.2337/db14-0496.
30. [30] Essawy, S.S., Abdel-Sater, K.A., Elbaz, A.A., Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acid. Archives Med. Sci. 10 (2014), 537–545, 10.5114/aoms.2013.33222.
31. [31] Hezel, M.P., Liu, M., Schiffer, T.A., Larsen, F.J., Checa, A., Wheelock, C.E., Carlström, M., Lundberg, J.O., Weitzberg, E., Effects of long-term dietary nitrate supplementation in mice. Redox Biol. 5 (2015), 234–242, 10.1016/j.redox.2015.05.004.
32. [32] Bouaziz-Ketata, H., Salah, G.B., Salah, H.B., Marrekchi, R., Jamoussi, K., Boudawara, T., Fakhfekh, F., Zeghal, N., Nitrate-induced biochemical and histopathological changes in the liver of rats: ameliorative effect of Hyparrhenia hirta. Biomed. Environ. Sci. 27 (2014), 695–706, 10.3967/bes2014.105.
33. [33] Til, H.P., Kuper, C.F., Falke, H.E., Nitrite-induced adrenal effects in rats and the consequences for the no-observed-effect level. Food Chem. Toxicol. 35 (1997), 349–355.
34. [34] Zahediasl, S., Ghasemi, A., Azizi, F., Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin. Biochem. 41 (2008), 1342–1347, 10.1016/j.clinbiochem.2008.08.076.
35. [35] Assmann, T.S., Brondani, L.A., Boucas, A.P., Rheinheimer, J., de Souza, B.M., Canani, L.H., Bauer, A.C., Crispim, D., Nitric oxide levels in patients with diabetes mellitus: a systematic review and meta-analysis. Nitric Oxide 61 (2016), 1–9, 10.1016/j.niox.2016.09.009 S1089-8603(16)30094-5 [pii].
36. [36] Schmetterer, L., Findl, O., Fasching, P., Ferber, W., Strenn, K., Breiteneder, H., Adam, H., Eichler, H.-G., Wolzt, M., Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 46 (1997), 653–658, 10.2337/diab.46.4.653.
37. [37] Smits, P., Hersbach, F.M.R.J., Jansen, T.L.T.A., Thien, T., Lutterman, J.A., Impaired vasodilator response to atrial natriuretic factor in IDDM. Diabetes 42 (1993), 1454–1461, 10.2337/diab.42.10.1454.
38. [38] Tsikas, D., Circulating and excretory nitrite and nitrate: their value as measures of nitric oxide synthesis, bioavailability and activity is inherently limited. Nitric Oxide 45 (2015), 1–3, 10.1016/j.niox.2015.01.001.
39. [39] Kim-Shapiro, D.B., Gladwin, M.T., Pitfalls in measuring NO bioavailability using NOx, nitric oxide. Biol. Chem./official J. Nitric Oxide Soc. 44 (2015), 1–2, 10.1016/j.niox.2014.10.003.
40. [40] Henquin, J.-C., Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 (2000), 1751–1760, 10.2337/diabetes.49.11.1751.
41. [41] Singamsetty, S., Watanabe, Y., Guo, L., Corey, C., Wang, Y., Tejero, J., McVerry, B.J., Gladwin, M.T., Shiva, S., O'Donnell, C.P., Inorganic nitrite improves components of the metabolic syndrome independent of weight change in a murine model of obesity and insulin resistance. J. Physiol. 593 (2015), 3135–3145, 10.1113/JP270386.
42. [42] Kruszelnicka, O., Nitric oxide vs insulin secretion, action and clearance. Diabetologia, 57, 2014, 257, 10.1007/s00125-013-3082-y.
43. [43] Steinke, J., Patel, T.N., Ammon, H.P., Relationship between glucose- and tolbutamide- induced insulin release and insulin content in single pancreatic rat islets. Metabolism 21 (1972), 465–470, 10.1016/0026-0495(72)90058-3.
44. [44] Hosokawa, Y.A., Leahy, J.L., Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats. Diabetes 46 (1997), 808–813, 10.2337/diab.46.5.808.
45. [45] Campbell, S.C., Richardson, H., Ferris, W.F., Butler, C.S., Macfarlane, W.M., Nitric oxide stimulates insulin gene transcription in pancreatic beta-cells. Biochem. Biophys. Res. Commun. 353 (2007), 1011–1016, 10.1016/j.bbrc.2006.12.127.
46. [46] El-Wakf, A.M., Hassan, H.A., Mahmoud, A.Z., Habza, M.N., Fenugreek potent activity against nitrate-induced diabetes in young and adult male rats. Cytotechnology 67 (2015), 437–447, 10.1007/s10616-014-9702-7.
47. [47] Meng, Q., Bueno, M., Kelly, N., Lai, Y., Mora, A.L., Gladwin, M.T., Evaluation of the therapeutic effects of nitrite and metformin in a mouse model of pulmonary hypertension associated with heart failure and preserved ejection fraction. Am. J. Respir. Crit. care Med., 193, 2016, A3888.
48. [48] Khoo, N.K.H., Mo, L., Zharikov, S., Kamga-Pride, C., Quesnelle, K., Golin-Bisello, F., Li, L., Wang, Y., Shiva, S., Nitrite augments glucose uptake in adipocytes through the protein kinase A-dependent stimulation of mitochondrial fusion. Free Radic. Biol. Med. 70 (2014), 45–53, 10.1016/j.freeradbiomed.2014.02.009.
49. [49] Ashmore, T., Roberts, L.D., Morash, A.J., Kotwica, A.O., Finnerty, J., West, J.A., Murfitt, S.A., Fernandez, B.O., Branco, C., Cowburn, A.S., Clarke, K., Johnson, R.S., Feelisch, M., Griffin, J.L., Murray, A.J., Nitrate enhances skeletal muscle fatty acid oxidation via a nitric oxide-cGMP-PPAR-mediated mechanism. BMC Biol., 13, 2015, 110, 10.1186/s12915-015-0221-6.
50. [50] Ren, X., Ding, Y., Lu, N., Nitrite attenuated peroxynitrite and hypochlorite generation in activated neutrophils. Eur. J. Pharmacol. 775 (2016), 50–56, 10.1016/j.ejphar.2016.02.020 S0014-2999(16)30043-7 [pii].
51. [51] Li, T., Lu, X., Sun, Y., Yang, X., Effects of spinach nitrate on insulin resistance, endothelial dysfunction markers and inflammation in mice with high-fat and high-fructose consumption. Food Nutr. Res., 60, 2016 32010. 32010 [pii].
52. [52] Zhao, G., Dharmadhikari, G., Maedler, K., Meyer-Hermann, M., Possible role of Interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies. PLoS Comput. Biol., 10, 2014, e1003798, 10.1371/journal.pcbi.1003798.
53. [53] Albersen, M., Lin, G., Fandel, T.M., Zhang, H., Qiu, X., Lin, C.S., Lue, T.F., Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction. Urology 78 (2011), 476.e1–476.e8, 10.1016/j.urology.2011.03.024.
54. [54] Razny, U., Kiec-Wilk, B., Wator, L., Polus, A., Dyduch, G., Solnica, B., Malecki, M., Tomaszewska, R., Cooke, J.P., Dembinska-Kiec, A., Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance. Cardiovasc Diabetol., 10, 2011, 68, 10.1186/1475-2840-10-68.
55. [55] Sadeghi-Hashjin, G., Abuhosseini, M., Asri-Rezaei, S., Role of nitric oxide in the plasma lipid profile in the rabbits. Archives Med. Sci. 5 (2009), 308–312.
56. [56] Smirnova, I.V., Sawamura, T., Goligorsky, M.S., Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency. Am. J. Physiol. Ren. Physiol. 287 (2004), F25–F32, 10.1152/ajprenal.00449.2003.
57. [57] Brownsey, R.W., Boone, A.N., Elliott, J.E., Kulpa, J.E., Lee, W.M., Regulation of acetyl-CoA carboxylase. Biochem. Soc. Trans. 34 (2006), 223–227, 10.1042/BST20060223.
58. [58] Meier, J.J., Bonadonna, R.C., Role of reduced beta-cell mass versus impaired beta-cell function in the pathogenesis of type 2 diabetes. Diabetes care 36 (2013), S113–S119, 10.2337/dcS13-2008.
59. [59] Yang, T., Peleli, M., Zollbrecht, C., Giulietti, A., Terrando, N., Lundberg, J.O., Weitzberg, E., Carlstrom, M., Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in activated macrophages via a nitric oxide-dependent mechanism. Free Radic. Biol. Med. 83 (2015), 159–166, 10.1016/j.freeradbiomed.2015.02.016.
60. [60] Carter, P., Gray, L.J., Troughton, J., Khunti, K., Davies, M.J., Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ, 341, 2010, c4229, 10.1136/bmj.c4229.
61. [61] McNally, B., Griffin, J.L., Roberts, L.D., Dietary inorganic nitrate: from villain to hero in metabolic disease?. Mol. Nutr. Food Res. 60 (2016), 67–78, 10.1002/mnfr.201500153.
62. [62] Hughes, W.E., Ueda, K., Treichler, D.P., Casey, D.P., Effects of acute dietary nitrate supplementation on aortic blood pressure and aortic augmentation index in young and older adults. Nitric Oxide 59 (2016), 21–27, 10.1016/j.niox.2016.06.007.
63. [63] Srinivasan, K., Ramarao, P., Animal models in type 2 diabetes research: an overview. Indian J. Med. Res. 125 (2007), 451–472.
64. [64] Gheibi, S., Bakhtiarzadeh, F., Ghasemi, A., A review of high fat diet-streptozotocin model for induction of type 2 diabetes in rat. Iran. J. Endocrinol. Metabolism 18 (2016), 135–148 (in persian).
65. [65] Mansor, L.S., Gonzalez, E.R., Cole, M.A., Tyler, D.J., Beeson, J.H., Clarke, K., Carr, C.A., Heather, L.C., Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin. Cardiovasc Diabetol., 12, 2013, 136, 10.1186/1475-2840-12-136.
66. [66] Khardori, R., Changing paradigms in type 2 diabetes mellitus. Indian J. Endocrinol. Metab. 17 (2013), S68–S71, 10.4103/2230-8210.119509.
67. [67] Furman, B.L., Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 70 (2015), 5.47.1–5.47.20, 10.1002/0471141755.ph0547s70.
68. [68] Sheykhzade, M., Dalsgaard, G.T., Johansen, T., Nyborg, N.C., The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: selective attenuation of CGRP-induced relaxations. Br. J. Pharmacol. 129 (2000), 1212–1218, 10.1038/sj.bjp.0703159.
69. [69] Ye, F., Shen, Z., Xie, M., Alpha-glucosidase inhibition from a Chinese medical herb (Ramulus mori) in normal and diabetic rats and mice. Phytomedicine 9 (2002), 161–166, 10.1078/0944-7113-00065 S0944-7113(04)70096-3 [pii].
70. [70] Clark, P.W., Jenkins, A.B., Kraegen, E.W., Pentobarbital reduces basal liver glucose output and its insulin suppression in rats. Am. J. Physiol. 258 (1990), E701–E707.
71. [71] Guarino, M.P., Santos, A.I., Mota-Carmo, M., Costa, P.F., Effects of anaesthesia on insulin sensitivity and metabolic parameters in Wistar rats. Vivo 27 (2013), 127–132.
72. [72] Johansen, O., Vaaler, S., Jorde, R., Reikeras, O., Increased plasma glucose levels after Hypnorm anaesthesia, but not after Pentobarbital anaesthesia in rats. Lab. Anim. 28 (1994), 244–248.